Uric acid levels in patients with multiple sclerosis: Analysis in mono- and dizygotic twins

Multiple Sclerosis

Volumn 7, Issue 3, 2001, Pages 165-166

  Spitsin, S ^a   Hooper, D C ^a   Mikheeva, T ^a   Koprowski, H ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Autoimmunity; Demyelinating diseases; Inosine; Multiple sclerosis; Twins; Uric acid

Indexed keywords

3 NITROTYROSINE; INOSINE; PEROXYNITRITE; SCAVENGER; URIC ACID;

ARTICLE; AUTOIMMUNITY; BLOOD ANALYSIS; BLOOD SAMPLING; BRAIN INJURY; COHORT ANALYSIS; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; DIZYGOTIC TWINS; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; MULTIPLE SCLEROSIS; URIC ACID BLOOD LEVEL;

FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; URIC ACID;

EID: 0034932843     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245801678438384     Document Type: Article

References (6)

1. Protection against peroxynitrite-dependent tyrosine nitration and α1-anti-proteinase inactivation by ascorbic acid. A comparison with other biologicaal antioxidats
2. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and ONOO - : Implications for the treatment of multiple sclerosis
3. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis
4. Correlation between urate level and clinical course of multiple sclerosis
5. Relative roles of genetic and environmental factors in the control of serum uric acid levels in normouricaemic subjects
6. Prospects for the treatmeent of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite